Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Full description

Bibliographic Details

Published in:	Российский кардиологический журнал
Main Authors:	S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2004-12-01
Subjects:	arterial hypertension metabolic syndrome cardioprotective effects rilmenidine
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2326